Hada maganin Corona ya haifar da cece-kuce .. Me ke faruwa

A yayin da Birtaniyya ke shirin yin shiri don mafi muni, batun hada alluran rigakafi da dama, domin ba wa wadanda suka samu kashi na farko na allurar Corona, ya jawo hankulan jama'a a kasar.

Bayan cikakkun bayanai game da shirin gaggawa na haɗa allurar rigakafin biyu da aka amince da su a cikin ƙaramin adadin lokuta (Pfizer da AstraZeneca ko Oxford) sun bazu, yawancin waɗanda ke da alhakin tsarin rigakafin sun shiga don kare wannan ra'ayi, a cewar jaridar Burtaniya, " The Guardian”.

Shawarwari yana haifar da guguwar suka

Labarin ya fara ne bayan wani littafi da jami'an kiwon lafiya na Burtaniya suka fitar ya ba da shawarar cewa "zai iya Sallama Kashi ɗaya na samfurin da ake samu a cikin gida don kammala jadawalin idan ba a samu allurar rigakafi iri ɗaya da aka yi amfani da ita don kashi na farko ba."

Amma rahoton ko littafin shawarwarin ya kara da cewa: "Babu wata shaida ta musayar alluran rigakafin Covid-19, amma har yanzu ana ci gaba da gudanar da bincike kan wannan tsarin."

Kogon jemage a China sun tona asirin Corona

"Babban ilimin"

Wannan abin lura ya haifar da cece-kuce da suka, an ƙarfafa shi tare da buga wani rahoto a cikin jaridar “New York Times” da ta yi ƙaulin ƙwararren masanin ilimin ƙwayoyin cuta Farfesa John Moore daga Jami’ar Cornell da ke Amurka yana cewa, “Babu cikakkun bayanai game da wannan ra’ayin ( hade alluran rigakafi ko jinkirta kashi na biyu na su) kwata-kwata, "in ji shi, ya kara da cewa jami'an Birtaniyya "sun daina kan kimiyya gaba daya, kuma da alama suna kokarin jin yadda za su fita daga wannan rikici."

Bi da bi, kwararre kan cututtuka na Amurka, Anthony Fauci, ya tabbatar a ranar Jumma'a, cewa bai yarda da tsarin Burtaniya ba dangane da jinkirta kashi na biyu na rigakafin Pfizer / BioNTech. Ya gaya wa CNN cewa Amurka ba za ta bi tsarin Birtaniyya ba, kuma za ta bi ka'idodin Pfizer da BioNTech don gudanar da kashi na biyu na rigakafinta makonni uku bayan na farko.

yanayi na musamman

A daya hannun, Dr Mary Ramsay, shugabar rigakafi a Ma'aikatar Kiwon Lafiyar Jama'a ta Ingila, ta yi bayanin cewa ba a ba da shawarar haɗuwa ba kuma zai faru ne kawai a cikin yanayi na musamman.

Ta kuma kara da cewa, "Idan kashi na farko shine Pfizer, bai kamata ku sami AstraZeneca don kashi na biyu ba kuma akasin haka. Amma ana iya samun lokuta da ba kasafai ake samun allurar rigakafi iri daya ba, ko kuma inda ba a san wace irin allurar da majiyyaci ya samu ba, lokacin da za a iya ba da wani maganin.

Ta kara da cewa, "Ya kamata a yi duk mai yiwuwa wajen ba su allurar rigakafi iri daya, amma idan hakan bai yiwu ba, yana da kyau a sake ba su kashi na biyu na wani maganin ba kwata-kwata."

Wannan dai na zuwa ne tare da samun gargadi daga asibitoci a fadin Biritaniya cewa dole ne su shirya wa mafi munin tunkarar sabon nau'in kwayar cutar Corona da ta rikide, da kuma fuskantar matsin lamba kamar yadda asibitocin kiwon lafiya ke fuskanta a Landan da kudu maso gabashin Ingila.